<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31793253</article-id><article-id pub-id-type="pmc">6894025</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2019-0317</article-id><article-categories><subj-group subj-group-type="heading"><subject>Special Article</subject></subj-group></article-categories><title-group><article-title>Endovascular Treatment of the Ascending Aorta: is this the Last Frontier in Aortic Surgery?</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-0126-0520</contrib-id><name><surname>Saadi</surname><given-names>Eduardo Keller</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="c1"/><role>MD</role><role>PhD</role></contrib><contrib contrib-type="author"><name><surname>Tagliari</surname><given-names>Ana Paula</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD</role><role>MSc</role></contrib><contrib contrib-type="author"><name><surname>Almeida</surname><given-names>Rui M. S.</given-names></name><xref ref-type="aff" rid="aff3">3</xref><role>MD</role><role>PhD</role></contrib></contrib-group><aff id="aff1">
<label>1</label>Departamento de Cirurgia Cardiovascular, Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.</aff><aff id="aff2">
<label>2</label>Departamento de Cirurgia Cardiovascular, Hospital S&#x000e3;o Lucas, Pontif&#x000ed;cia Universidade Cat&#x000f3;lica do Rio Grande do Sul, Porto Alegre, RS, Brazil.</aff><aff id="aff3">
<label>3</label>Departamento de Cirurgia Cardiovascular, Faculdade de Medicina, Centro Universit&#x000e1;rio Funda&#x000e7;&#x000e3;o Assis Gurgacz, Universidade Estadual do Oeste, Cascavel, PR, Brazil.</aff><author-notes><corresp id="c1">Correspondence Address: <bold>Eduardo Keller Saadi</bold>, <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0002-0126-0520">https://orcid.org/0000-0002-0126-0520</ext-link>, Departamento de Cirurgia Cardiovascular, Hospital S&#x000e3;o Lucas, Pontif&#x000ed;cia Universidade Cat&#x000f3;lica do Rio Grande do Sul, Rua Ramiro Barcellos, 2350, Porto Alegre, RS, Brazil. Zip Code: 90035-903. E-mail: <email>esaadi@terra.com.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Nov-Dec</season><year>2019</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Nov-Dec</season><year>2019</year></pub-date><volume>34</volume><issue>6</issue><fpage>759</fpage><lpage>764</lpage><history><date date-type="received"><day>07</day><month>8</month><year>2019</year></date><date date-type="accepted"><day>17</day><month>8</month><year>2019</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Regardless the successful treatment of the descending aorta with endovascular prosthesis, for the ascending aorta segment, because of several anatomic and physiologic issues, this technique has been considered an alternative only for high-risk or inoperable patients. Despite restricted indications, hundreds of treatments have been performed worldwide, demonstrating its safety and reproducibility if it is done in high-quality centers. Therefore, understanding patients&#x02019; selection criteria and technique limitations are critical to its application.</p></abstract><kwd-group><kwd>Ascending Aorta</kwd><kwd>Cardiac Surgery</kwd><kwd>Endovascular Procedures</kwd><kwd>Endovascular Surgery</kwd><kwd>Thoracic Endovascular Repair</kwd></kwd-group></article-meta></front><body><table-wrap id="t1" orientation="portrait" position="anchor"><table frame="hsides" rules="groups" style="background-color:#e6e7e8"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Abbreviations, acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">BCT</td><td align="left" rowspan="1" colspan="1">= Brachiocephalic trunk</td></tr><tr><td align="left" rowspan="1" colspan="1">CT</td><td align="left" rowspan="1" colspan="1">= Computed tomography</td></tr><tr><td align="left" rowspan="1" colspan="1">ESC</td><td align="left" rowspan="1" colspan="1">= European Society of Cardiology</td></tr><tr><td align="left" rowspan="1" colspan="1">GREAT</td><td align="left" rowspan="1" colspan="1">= Global Registry for Endovascular Aortic Treatment</td></tr><tr><td align="left" rowspan="1" colspan="1">SG</td><td align="left" rowspan="1" colspan="1">= Stent graft</td></tr><tr><td align="left" rowspan="1" colspan="1">STJ</td><td align="left" rowspan="1" colspan="1">= Sinotubular junction</td></tr><tr><td align="left" rowspan="1" colspan="1">TAAD</td><td align="left" rowspan="1" colspan="1">= Type A aortic dissection</td></tr><tr><td align="left" rowspan="1" colspan="1">TEVAR</td><td align="left" rowspan="1" colspan="1">= Thoracic aorta endovascular repair</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>The concept of treating the ascending thoracic aorta with endoprosthesis emerged after the first-in-man successful case described by Dorros et al.<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup> in 2000. Since then, several studies have reported the safety and effectiveness of the ascending aorta endovascular repair.</p><p>Despite this, contrasting with the descending aorta, where thoracic aorta endovascular repair (TEVAR) is well established<sup>[<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref>]</sup>, for proximal aortic disease, open surgery is considered the gold standard for treatment, although less invasive procedures are achieving an important role, especially in high-risk or inoperable patients.</p><p>The need for an alternative treatment becomes even more relevant when considering that more than 20% of the patients with type A aortic dissection (TAAD) are deemed inoperable<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>. In this context, ascending TEVAR could have potential advantages, such as absence of thoracotomy incision and need for partial or total extracorporeal circulatory support, as well as lower hospital morbidity rates and shorter length of hospital stay when compared to open surgery<sup>[<xref rid="r5" ref-type="bibr">5</xref>,<xref rid="r6" ref-type="bibr">6</xref>]</sup>. This was already well established on our initial experience<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup> (<xref ref-type="fig" rid="f1">Figures 1</xref> and <xref ref-type="fig" rid="f2">2</xref>).</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Computed tomography post stent graft in ascending aorta.</p></caption><graphic xlink:href="rbccv-34-06-0759-g01"/></fig>
</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Computed tomography, axial view, post stent graft in ascending aorta.</p></caption><graphic xlink:href="rbccv-34-06-0759-g02"/></fig>
</p><sec><title>Indications and Planning</title><p>According to the 2014 European Society of Cardiology (ESC) Guidelines on diagnosis and treatment of aortic diseases, the use of TEVAR should be decided on an individual basis, according to the anatomy, pathology, comorbidity, and anticipated durability criteria, using a multidisciplinary approach (Class I, Level C)<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>.</p><p>Planning the procedure, this guideline reinforces that it is mandatory to perform preoperative imaging and engineering analysis, with contrast-enhanced computed tomography (CT) representing the imaging modality of choice<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>.</p><p>CT planning is indispensable because the ascending aorta has some particular characteristics different from the other segments, like its size, shape, hemodynamic forces, and proximity to other anatomic structures (<xref ref-type="fig" rid="f3">Figure 3</xref>). Moreover, more complex anatomy and pathologies are frequently detected in the ascending segment<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>.</p><p>
<fig id="f3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Ascending aortic dissection. Planning endovascular treatment with preoperative contrast-enhanced computed tomography.</p></caption><graphic xlink:href="rbccv-34-06-0759-g03"/></fig>
</p></sec><sec><title>Surgical Technique</title><p>As ascending aorta endovascular treatment involves several challenges and potential catastrophic complications<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>, these procedures should be done in a hybrid room, with cardiopulmonary bypass available, as well as transesophageal echocardiogram and transvenous pacemaker, and by a surgical team well trained on both procedures (conventional and endovascular)<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>.</p><p>Regarding anatomical suitability criteria, a landing zone of at least 2 cm, an aortic diameter &#x0003c; 40 mm<sup>[<xref rid="r8" ref-type="bibr">8</xref>-<xref rid="r11" ref-type="bibr">11</xref>]</sup>, an absence of grade 3/4 regurgitation, and iliofemoral vessels with a diameter &#x0003e; 7 mm and an angulation &#x0003c; 90&#x000b0; (for 24-French delivery system) have been required. Besides this, in cases of TAAD, a distance from the entry tear to the coronary ostia &#x0003e; 20 mm is also mandatory<sup>[<xref rid="r12" ref-type="bibr">12</xref>-<xref rid="r14" ref-type="bibr">14</xref>]</sup>.</p><p>As mentioned by Muetterties et al.<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>, these criteria are critical because the proximity between the endoprosthesis proximal landing zone and the aortic valve or the coronary ostia could result in aortic insufficiency or myocardial infarction if the stent graft (SG) is accidentally deployed in a proximal position. Likewise, distal stent migration could lead to brachiocephalic artery occlusion, resulting in stroke. Therefore, the ideal candidates for an ascending TEVAR procedure are patients with focal aortic defects, including pseudoaneurysms and ascending aortic dissections with focal entry tears in the middle third of the ascending aorta.</p><p>Conformability of the device to fit the aorta curvature and to provide a better seal along entry tears is also an important characteristic. Thus, for chronic disease, it is recommended an oversizing by about 20%, instead of the typical 10% recommended for acute dissections<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>.</p><p>According to Moon et al.<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>, for patients with TAAD evaluated by CT, other endograft suitability criteria are an adequate proximal landing zone (sinotubular junction [STJ] &#x02264; 38 mm), fenestration distal to STJ, minimum distance between intimal fenestration and STJ &#x02265; 10 mm, and absence of coronary bypass grafts originating from the ascending aorta.</p><p>Moreover, based on findings of the Global Registry for Endovascular Aortic Treatment (GREAT), Piffareti et al.<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup> demonstrated that the most adequate SG size was selected using a three-dimensional centerline reconstruction workstation. For aortic dissection and pseudoaneurysm, an SG diameter equal to the wall-to-wall diameter without oversizing was used. For aortic aneurysms, the SG was oversized 20% based on the larger of two measurements performed at the STJ or at the distal ascending aorta. The authors also described that the SG should be ideally deployed under temporary overdrive cardiac pacing, generally, 190 beats/min.</p><p>The most common access sites are the transfemoral, transapical, or axillary arteries, being the last two a potential alternative when the anatomy is unfit for a standard retrograde approach<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>.</p></sec><sec><title>Available Devices</title><p>TEVAR in the ascending aorta segment can be performed with dedicated ascending aortic SG (Zenith Ascend TAA Endovascular Graft, William Cook Europe, Bjaeverskov, Denmark), a standardized device or a surgeon-modified thoracic SG<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup> (<xref ref-type="fig" rid="f4">Figures 4</xref> and <xref ref-type="fig" rid="f5">5</xref>).</p><p>
<fig id="f4" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>Three-dimensional computed tomography post stent graft in ascending aorta.</p></caption><graphic xlink:href="rbccv-34-06-0759-g04"/></fig>
</p><p>
<fig id="f5" orientation="portrait" position="float"><label>Fig. 5</label><caption><p>Three-dimensional computed tomography post stent graft in type A aortic dissection.</p></caption><graphic xlink:href="rbccv-34-06-0759-g05"/></fig>
</p><p>Limitations to use standard thoracic SG in TAAD are the location of the intimal tear, presence of higher-grade aortic valve insufficiency, and an aortic diameter &#x0003e; 38 mm<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup>.</p><p>A concerning point is that the majority of the SGs currently available on the market are too long for ascending aorta deployment or have a too long nose cone, which could interfere with the native aortic valve during the deployment, leading to a necessity of customization or intraoperative modification of the devices<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup> (<xref ref-type="fig" rid="f4">Figure 4</xref>). Some devices also have a delivery system length that does not reach ascending aorta in big patients or patients with angulated aortas.</p></sec><sec><title>Procedure Complications</title><p>The most important complications in ascending TEVAR are cardiac tamponade, stroke, endoleak, stent distal migration, residual dissection, aneurysm, left ventricle perforation, injury and dissection of the aortic root, and occlusion of the coronary arteries<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>.</p><p>Some of the advantages in this procedure concern the fewer cases of endoleak, as stated by Khoynezhad et al.<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>, who highlighted that the absence of side branches in the ascending aorta makes type II endoleak not possible. The same applies to type III endoleak, in cases where just one graft is deployed, this complication is inexistent. Therefore, endoleaks observed in ascending aorta TEVAR are mainly type Ia and Ib.</p></sec><sec><title>Available Outcomes</title><p>In terms of clinical results, in 2015, Roselli EE et al.<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup> published their own experience with 22 patients enrolled from 2006 to 2014 at the Cleveland Clinic. Cases of acute TAAD, intramural hematoma, pseudoaneurysm, chronic dissection, or aorta-cardiac fistula have undergone supracoronary ascending TEVAR procedure. Acceptable hospital mortality (13.6%) and an actual survival rate at 30 days, one year, and five years of 86%, 80%, and 75%, respectively, were demonstrated.</p><p>The same authors, in 2018, published a new article proposing a modification in the landing zone classification based on the evaluation of 39 patients, 36 of them managed with TEVAR. CT imaging analysis was performed, and the extent of aortic pathology was designated by the segmental proximity to the left ventricle, by diving the zone zero into three segments: a) zone 0A constitutes the aortic root and is defined proximally by the left ventricular outflow tract and distally by the distal edge of the coronary ostia; b) zone 0B constitutes the proximal half of the ascending aorta and is defined as the region between the distal coronary ostia and the right main pulmonary artery; c) zone 0C is the distal half of the ascending aorta extending from the right main pulmonary artery and including the brachiocephalic trunk (BCT)<sup>[<xref rid="r23" ref-type="bibr">23</xref>]</sup>.</p><p>Multivariable analysis of this cohort demonstrated a significantly higher hazard of mortality in diseases involving zone 0A <italic>vs</italic>. 0C (<italic>P</italic>=0.020) and in the elderly (<italic>P</italic>=0.026). At 30 days, one year, and five years, the overall survival rate was 81%, 74%, and 64% and the freedom from reintervention was 85%, 77%, and 68%, respectively<sup>[<xref rid="r23" ref-type="bibr">23</xref>]</sup>.</p><p>Tsilimparis N et al.<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup> similarly reported their experiences with 24 high-risk unsuitable for open repair patients. Pathologies included acute aortic dissection, chronic dissection, and pseudoaneurysm. The 30-day survival rate was 79% and major adverse events occurred in six (25%) patients, with a reintervention rate of 12.5%.</p><p>Unifying the case and series reports, Muetterties et al.<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup> recently published a systematic review comprising 46 publications with a total of 118 patients treated for different aortic diseases: TAAD (50%), aortic pseudoaneurysms (30%), aortic aneurysm (5%), penetrating atherosclerotic ulcer (4.2%), or acute aortic rupture (2.5%). In this review, 13 different aortic SG of various designs were used, most commonly the thoracic stents (71%), abdominal cuffs (1%), and custom-made grafts (10%). In this analysis, femoral arterial access was used in 62.7%, transapical in 14.4%, carotid in 12.7%, and axillary in 6.8% of the patients. In an average follow-up of 17.2 months, type I endoleak was diagnosed in 18.6% (with 9.3% requiring reintervention), the rate of all-cause mortality was 15.2%, aorta-related mortality was 5%, conversion to open surgery occurred in 3.4%, and cerebrovascular complications occurred in 3.4% of the patients<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>.</p><p>Another similar meta-analysis of 30 articles identified a high rate of prior cardiac operation (67%) in a total population of 119 patients managed with TEVAR in the ascending aorta. Technical success was achieved in 95.5%, conversion to open repair in 0.7%, neurologic events in 1.8%, myocardial infarction in 0.8%, and 30-days mortality was 2.9%<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>.</p><p>Analyzing exclusively non-dissected ascending aorta disease, systematic review encompassing 67 patients (mean age 65&#x000b1;17 years) reported early mortality of 2.9%, endoleak rate of 13.4%, stroke of 4.8%, and non-ST-elevation myocardial infarction of 1.5%. Six patients (8.9%) required reintervention after endovascular repair (five required open surgery and one endovascular reintervention for an endoleak). The authors observed that the devices used were off-the-shelf, custom-designed, or modified-design SG and the average length of the SG was 66.9&#x000b1;25.9 mm<sup>[<xref rid="r25" ref-type="bibr">25</xref>]</sup>.</p><p>Even in cases where the aortic valve is compromised, the concept of a proximal transcatheter aortic valve connected to an uncovered portion of an SG (&#x0201c;endo Bentall&#x0201d;) is emerging. This could result in shorter landing zones and, therefore, could increase the number of patients suitable for endovascular treatment<sup>[<xref rid="r26" ref-type="bibr">26</xref>]</sup>.</p><p>In terms of national experiences, in 2011, Saadi et al.<sup>[<xref rid="r27" ref-type="bibr">27</xref>]</sup> reported two successful lifesaving cases of patients with ascending aorta pseudoaneurysm managed with implantation of SG together with percutaneous coronary intervention secondary to ischemic disease, proving the feasibility of the combined method<sup>[<xref rid="r27" ref-type="bibr">27</xref>]</sup> (<xref ref-type="fig" rid="f6">Figure 6</xref>).</p><p>
<fig id="f6" orientation="portrait" position="float"><label>Fig. 6</label><caption><p>Use of two stent grafts for correction of ascending aorta pseudoaneurysm and coronary stent on right coronary artery.</p></caption><graphic xlink:href="rbccv-34-06-0759-g06"/></fig>
</p></sec></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>Ascending aorta TEVAR represents the final frontier of endovascular therapy and it is well proven to be a lifesaving procedure in selected patients, using customized or off-the-shelf endoprosthesis. There are still several anatomical, physiological, and technical challenges, such as the short distance between coronary arteries and BCT, aortic valve regurgitation and obstruction, high hemodynamic forces, angulation, coronary arteries, and cerebral perfusion. Potential serious complications like aortic dissection, rupture, coronary and BCT obstruction, and aortic valve damage require a well-trained multidisciplinary team in a hybrid room environment. Therefore, understanding patients&#x02019; selection criteria, limitations of the technology, and development of dedicated devices are critical to its application. Trials are needed to provide evidence-based data.</p><table-wrap id="t2" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">EKS</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">APT</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">RMSA</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at the Departamento de Cirurgia Cardiovascular, Hospital S&#x000e3;o Lucas, Pontif&#x000ed;cia Universidade Cat&#x000f3;lica do Rio Grande do Sul, Porto Alegre, RS, Brazil.</p></fn><fn fn-type="financial-disclosure"><p><bold>No financial support.</bold></p></fn><fn fn-type="COI-statement"><p><bold>No conflict of interest.</bold></p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorros</surname><given-names>G</given-names></name><name><surname>Dorros</surname><given-names>AM</given-names></name><name><surname>Planton</surname><given-names>S</given-names></name><name><surname>O'Hair</surname><given-names>D</given-names></name><name><surname>Zayed</surname><given-names>M</given-names></name></person-group><article-title>Transseptal guidewire stabilization facilitates stent-graft deployment for persistent proximal ascending aortic dissection</article-title><source>J Endovasc Ther</source><year>2000</year><volume>7</volume><issue>6</issue><fpage>506</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.1177/152660280000700612</pub-id><pub-id pub-id-type="pmid">11194823</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>D</given-names></name><name><surname>Martin</surname><given-names>J</given-names></name><name><surname>Shennib</surname><given-names>H</given-names></name><name><surname>Dunning</surname><given-names>J</given-names></name><name><surname>Muneretto</surname><given-names>C</given-names></name><name><surname>Schueler</surname><given-names>S</given-names></name><etal/></person-group><article-title>Endovascular aortic repair versus open surgical repair for descending thoracic aortic disease: A systematic review and meta-analysis of comparative studies</article-title><source>J Am Coll Cardiol</source><year>2010</year><volume>55</volume><issue>10</issue><fpage>986</fpage><lpage>1001</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2009.11.047</pub-id><pub-id pub-id-type="pmid">20137879</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nienaber</surname><given-names>CA</given-names></name><name><surname>Kische</surname><given-names>S</given-names></name><name><surname>Rousseau</surname><given-names>H</given-names></name><name><surname>Eggebrecht</surname><given-names>H</given-names></name><name><surname>Rehders</surname><given-names>TC</given-names></name><name><surname>Kundt</surname><given-names>G</given-names></name><etal/></person-group><article-title>Endovascular repair of type B aortic dissection: Long-term results of the randomized investigation of stent grafts in aortic dissection trial</article-title><source>Circ Cardiovasc Interv</source><year>2013</year><volume>6</volume><issue>4</issue><fpage>407</fpage><lpage>416</lpage><pub-id pub-id-type="doi">10.1161/circinterventions.113.000463</pub-id><pub-id pub-id-type="pmid">23922146</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trimarchi</surname><given-names>S</given-names></name><name><surname>Nienaber</surname><given-names>CA</given-names></name><name><surname>Rampoldi</surname><given-names>V</given-names></name></person-group><article-title>Contemporary results of surgery in acute type A aortic dissection: The International Registry of Acute Aortic Dissection experience</article-title><source>J Thorac Cardiovasc Surg</source><year>2005</year><volume>129</volume><fpage>112</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1016/j.accreview.2005.04.039</pub-id><pub-id pub-id-type="pmid">15632832</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiratzka</surname><given-names>LF</given-names></name><name><surname>Bakris</surname><given-names>GL</given-names></name><name><surname>Beckman</surname><given-names>JA</given-names></name><name><surname>Bersin</surname><given-names>RM</given-names></name><name><surname>Carr</surname><given-names>VF</given-names></name><name><surname>Casey</surname><given-names>DE Jr</given-names></name><etal/></person-group><article-title>2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine</article-title><source>Circulation</source><year>2010</year><volume>121</volume><issue>13</issue><fpage>e266</fpage><lpage>e369</lpage><pub-id pub-id-type="doi">10.1161/CIR.0b013e3181d4739e</pub-id><pub-id pub-id-type="pmid">20233780</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baikoussis</surname><given-names>NG</given-names></name><name><surname>Antonopoulos</surname><given-names>CN</given-names></name><name><surname>Papakonstantinou</surname><given-names>NA</given-names></name><name><surname>Argiriou</surname><given-names>M</given-names></name><name><surname>Geroulakos</surname><given-names>G</given-names></name></person-group><article-title>Endovascular stent grafting for ascending aorta diseases</article-title><source>J Vasc Surg</source><year>2017</year><month>11</month><volume>66</volume><issue>5</issue><fpage>1587</fpage><lpage>1601</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2017.07.064</pub-id><pub-id pub-id-type="pmid">28830707</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Saadi</surname><given-names>EK</given-names></name><name><surname>Almeida</surname><given-names>RMS</given-names></name><name><surname>Zago</surname><given-names>AC</given-names></name></person-group><chapter-title>Endovascular Treatment of Ascending Aorta: The Last Frontier?</chapter-title><person-group person-group-type="editor"><name><surname>Wilbert</surname><given-names>S. Aronow</given-names></name></person-group><source>Artery Bypass. IntechOpen</source><year>2013</year><fpage>413</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.5772/55149</pub-id><ext-link ext-link-type="uri" xlink:href="http://www.intechopen.com/books/artery-bypass/endovascular-treatment-of-ascending-aorta-the-last-frontier">http://www.intechopen.com/books/artery-bypass/endovascular-treatment-of-ascending-aorta-the-last-frontier</ext-link></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erbel</surname><given-names>R</given-names></name><name><surname>Aboyans</surname><given-names>V</given-names></name><name><surname>Boileau</surname><given-names>C</given-names></name><name><surname>Bossone</surname><given-names>E</given-names></name><name><surname>Bartolomeo</surname><given-names>RD</given-names></name><name><surname>Eggebrecht</surname><given-names>H</given-names></name><etal/></person-group><article-title>ESC Committee for Practice Guidelines. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC)</article-title><source>Eur Heart J</source><year>2014</year><volume>35</volume><issue>41</issue><fpage>2873</fpage><lpage>2926</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehu281</pub-id><pub-id pub-id-type="pmid">25173340</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roselli</surname><given-names>EE</given-names></name><name><surname>Idrees</surname><given-names>J</given-names></name><name><surname>Greenberg</surname><given-names>RK</given-names></name><name><surname>Johnston</surname><given-names>DR</given-names></name><name><surname>Lytle</surname><given-names>BW</given-names></name></person-group><article-title>Endovascular stent grafting for ascending aorta repair in high-risk patients</article-title><source>J Thorac Cardiovasc Surg</source><year>2015</year><volume>149</volume><issue>1</issue><fpage>144</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1016/j.jtcvs.2014.07.109</pub-id><pub-id pub-id-type="pmid">25312226</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plichta</surname><given-names>RP</given-names></name><name><surname>Hughes</surname><given-names>GC</given-names></name></person-group><article-title>Thoracic endovascular aortic repair for the ascending aorta: experience and pitfalls</article-title><source>J Vis Surg</source><year>2018</year><month>5</month><day>09</day><volume>4</volume><issue>5</issue><fpage>92</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.21037/jovs.2018.03.01</pub-id><pub-id pub-id-type="pmid">29963381</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almeida</surname><given-names>RMSSA</given-names></name></person-group><article-title>The cardiovascular surgeon as an interventionist</article-title><source>Rev Bras Cir Cardiovasc</source><year>2009</year><volume>24</volume><issue>2 Suppl</issue><fpage>35s</fpage><lpage>37s</lpage><pub-id pub-id-type="doi">10.1590/S0102-76382009000300005</pub-id><pub-id pub-id-type="pmid">19768316</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Q</given-names></name><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Bao</surname><given-names>J</given-names></name><name><surname>Feng</surname><given-names>R</given-names></name><etal/></person-group><article-title>Endovascular repair of ascending aortic dissection: a novel treatment option for patients judged unfit for direct surgical repair</article-title><source>J Am Coll Cardiol</source><year>2013</year><volume>61</volume><issue>18</issue><fpage>1917</fpage><lpage>1924</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2012.08.994</pub-id><pub-id pub-id-type="pmid">23122798</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Preventza</surname><given-names>O</given-names></name><name><surname>Henry</surname><given-names>MJ</given-names></name><name><surname>Cheong</surname><given-names>BYC</given-names></name><name><surname>Coselli</surname><given-names>JS</given-names></name></person-group><article-title>Endovascular repair of the ascending aorta: when and how to implement the current technology</article-title><source>Ann Thorac Surg</source><year>2014</year><volume>97</volume><issue>5</issue><fpage>1555</fpage><lpage>1560</lpage><pub-id pub-id-type="doi">10.1016/j.athoracsur.2013.11.066</pub-id><pub-id pub-id-type="pmid">24518571</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ronchey</surname><given-names>S</given-names></name><name><surname>Serrao</surname><given-names>E</given-names></name><name><surname>Alberti</surname><given-names>V</given-names></name><name><surname>Fazzini</surname><given-names>S</given-names></name><name><surname>Trimarchi</surname><given-names>S</given-names></name><name><surname>Tolenaar</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Endovascular stenting of the ascending aorta for type A aortic dissections in patients at high risk for open surgery</article-title><source>Eur J Vasc Endovasc Surg</source><year>2013</year><volume>45</volume><issue>5</issue><fpage>475</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1016/j.ejvs.2013.01.033</pub-id><pub-id pub-id-type="pmid">23465453</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muetterties</surname><given-names>CE</given-names></name><name><surname>Menon</surname><given-names>R</given-names></name><name><surname>Wheatley 3rd</surname><given-names>GH</given-names></name></person-group><article-title>A systematic review of primary endovascular repair of the ascending aorta</article-title><source>J Vasc Surg</source><year>2018</year><volume>67</volume><issue>1</issue><fpage>332</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2017.06.099</pub-id><pub-id pub-id-type="pmid">28844469</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sobocinski</surname><given-names>J</given-names></name><name><surname>O'Brien</surname><given-names>N</given-names></name><name><surname>Maurel</surname><given-names>B</given-names></name><name><surname>Bartoli</surname><given-names>M</given-names></name><name><surname>Goueffic</surname><given-names>Y</given-names></name><name><surname>Sassard</surname><given-names>T</given-names></name><etal/></person-group><article-title>Endovascular approaches to acute aortic type A dissection: a CT-based feasibility study</article-title><source>Eur J Vasc Endovasc Surg</source><year>2011</year><volume>42</volume><issue>4</issue><fpage>442</fpage><lpage>447</lpage><pub-id pub-id-type="doi">10.1016/j.ejvs.2011.04.037</pub-id><pub-id pub-id-type="pmid">21764338</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moon</surname><given-names>MC</given-names></name><name><surname>Greenberg</surname><given-names>RK</given-names></name><name><surname>Morales</surname><given-names>JP</given-names></name><name><surname>Martin</surname><given-names>Z</given-names></name><name><surname>Lu</surname><given-names>Q</given-names></name><name><surname>Dowdall</surname><given-names>JF</given-names></name><etal/></person-group><article-title>Computed tomography-based anatomic characterization of proximal aortic dissection with consideration for endovascular candidacy</article-title><source>J Vasc Surg</source><year>2011</year><volume>53</volume><issue>4</issue><fpage>942</fpage><lpage>949</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2010.10.067</pub-id><pub-id pub-id-type="pmid">21345636</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piffaretti</surname><given-names>G</given-names></name><name><surname>Grassi</surname><given-names>V</given-names></name><name><surname>Lomazzi</surname><given-names>C</given-names></name><name><surname>Brinkman</surname><given-names>WT</given-names></name><name><surname>Navarro</surname><given-names>TP</given-names></name><name><surname>Jenkins</surname><given-names>MP</given-names></name><etal/></person-group><article-title>GREAT participants: Thoracic endovascular stent graft repair for ascending aortic diseases</article-title><source>J Vasc Surg</source><year>2019</year><fpage>S0741</fpage><lpage>S5214</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2019.01.075</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murakami</surname><given-names>T</given-names></name><name><surname>Nishimura</surname><given-names>S</given-names></name><name><surname>Hosono</surname><given-names>M</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Sohgawa</surname><given-names>E</given-names></name><name><surname>Sakai</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Transapical endovascular repair of thoracic aortic pathology</article-title><source>Ann Vasc Surg</source><year>2017</year><volume>43</volume><fpage>56</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/j.avsg.2016.10.054</pub-id><pub-id pub-id-type="pmid">28288887</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsilimparis</surname><given-names>N</given-names></name><name><surname>Debus</surname><given-names>ES</given-names></name><name><surname>Oderich</surname><given-names>GS</given-names></name><name><surname>Haulon</surname><given-names>S</given-names></name><name><surname>Terp</surname><given-names>KA</given-names></name><name><surname>Roeder</surname><given-names>B</given-names></name><etal/></person-group><article-title>International experience with endovascular therapy of the ascending aorta with a dedicated endograft</article-title><source>J Vasc Surg</source><year>2016</year><month>6</month><volume>63</volume><issue>6</issue><fpage>1476</fpage><lpage>1482</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2015.12.027</pub-id><pub-id pub-id-type="pmid">26926935</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaussaud</surname><given-names>N</given-names></name><name><surname>Chitsaz</surname><given-names>S</given-names></name><name><surname>Meadows</surname><given-names>A</given-names></name><name><surname>Wintermark</surname><given-names>M</given-names></name><name><surname>Cambronero</surname><given-names>N</given-names></name><name><surname>Azadani</surname><given-names>AN</given-names></name><etal/></person-group><article-title>Acute type A aortic dissection intimal tears by 64-slice computed tomography: A role for endovascular stent-grafting?</article-title><source>J Cardiovasc Surg (Torino)</source><year>2013</year><volume>54</volume><issue>3</issue><fpage>373</fpage><lpage>381</lpage></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khoynezhad</surname><given-names>A</given-names></name><name><surname>Donayre</surname><given-names>CE</given-names></name><name><surname>Walot</surname><given-names>I</given-names></name><name><surname>Koopmann</surname><given-names>MC</given-names></name><name><surname>Kopchok</surname><given-names>GE</given-names></name><name><surname>White</surname><given-names>RA</given-names></name></person-group><article-title>Feasibility of endovascular repair of ascending aortic pathologies as part of an FDA-approved physician-sponsored investigational device exemption</article-title><source>J Vasc Surg</source><year>2016</year><volume>63</volume><issue>6</issue><fpage>1483</fpage><lpage>1495</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2015.12.029</pub-id><pub-id pub-id-type="pmid">26926938</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roselli</surname><given-names>EE</given-names></name><name><surname>Idrees</surname><given-names>JJ</given-names></name><name><surname>Johnston</surname><given-names>DR</given-names></name><name><surname>Eagleton</surname><given-names>MJ</given-names></name><name><surname>Desai</surname><given-names>MY</given-names></name><name><surname>Svensson</surname><given-names>LG</given-names></name></person-group><article-title>Zone zero thoracic endovascular aortic repair: A proposed modification to the classification of landing zones</article-title><source>J Thorac Cardiovasc Surg</source><year>2018</year><volume>155</volume><issue>4</issue><fpage>1381</fpage><lpage>1389</lpage><pub-id pub-id-type="doi">10.1016/j.jtcvs.2017.11.054</pub-id><pub-id pub-id-type="pmid">29395197</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsilimparis</surname><given-names>N</given-names></name><name><surname>Drewitz</surname><given-names>S</given-names></name><name><surname>Detter</surname><given-names>C</given-names></name><name><surname>Spanos</surname><given-names>K</given-names></name><name><surname>von Kodolitsch</surname><given-names>Y</given-names></name><name><surname>Rohlffs</surname><given-names>F</given-names></name><etal/></person-group><article-title>Endovascular repair of ascending aortic pathologies with tubular endografts: A single-center experience</article-title><source>J Endovasc Ther</source><year>2019</year><month>8</month><volume>26</volume><issue>4</issue><fpage>439</fpage><lpage>444</lpage><pub-id pub-id-type="doi">10.1177/1526602819852083</pub-id><pub-id pub-id-type="pmid">31140362</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Regar</surname><given-names>E</given-names></name><name><surname>Lachat</surname><given-names>M</given-names></name><name><surname>von Segesser</surname><given-names>LK</given-names></name><name><surname>Maisano</surname><given-names>F</given-names></name><name><surname>Ferrari</surname><given-names>E</given-names></name></person-group><article-title>Endovascular treatment of non-dissected ascending aorta disease: a systematic review</article-title><source>Eur J Cardiothorac Surg</source><year>2018</year><volume>53</volume><issue>2</issue><fpage>317</fpage><lpage>324</lpage><pub-id pub-id-type="doi">10.1093/ejcts/ezx308</pub-id><pub-id pub-id-type="pmid">28958041</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rylski</surname><given-names>B</given-names></name><name><surname>Szeto</surname><given-names>WY</given-names></name><name><surname>Bavaria</surname><given-names>JE</given-names></name><name><surname>Branchetti</surname><given-names>E</given-names></name><name><surname>Moser</surname><given-names>W</given-names></name><name><surname>Milewski</surname><given-names>RK</given-names></name></person-group><article-title>Development of a single endovascular device for aortic valve replacement and ascending aortic repair</article-title><source>J Card Surg</source><year>2014</year><volume>29</volume><issue>3</issue><fpage>371</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1111/jocs.12348</pub-id><pub-id pub-id-type="pmid">24762037</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saadi</surname><given-names>EK</given-names></name><name><surname>Moura</surname><given-names>LD</given-names></name><name><surname>Zago</surname><given-names>A</given-names></name><name><surname>Zago</surname><given-names>A</given-names></name></person-group><article-title>Endovascular repair of ascending aorta and coronary stent implantation</article-title><source>Rev Bras Cir Cardiovasc</source><year>2011</year><volume>26</volume><issue>3</issue><fpage>477</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.5935/1678-9741.20110025</pub-id><pub-id pub-id-type="pmid">22086587</pub-id></element-citation></ref></ref-list></back></article>